Research News and Research

RSS

Sleeping with baby: the dangers quantified

According to Victorian coroner John Olle there are an “alarming” number of infant co-sleeping deaths in Victoria. Figures reveal that 33 of the 72 unexplained child deaths in the past three years occurred in circumstances where a child shared a bed with an adult.

3 Oct 2011

Discovery of ‘alarm-clock’ gene

Researchers led by Indian-American scientist, Satchidananda Panda at the Salk Institute for Biological Studies in La Jolla, Calif., said the gene is responsible for starting the body’s biological clock from its restful state every morning. They add that this may open avenues in research in insomnia or sleeplessness, aging and chronic illnesses.

3 Oct 2011

Novel drug shows promise for MLL leukemia

According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.

3 Oct 2011

Interactive video games appear valuable for ICU patients

Interactive video games, already known to improve motor function in recovering stroke patients, appear to safely enhance physical therapy for patients in intensive care units (ICU), new research from Johns Hopkins suggests.

3 Oct 2011

Over 13,000 youth to receive cardiac screenings in Oct.

During National Sudden Cardiac Arrest Awareness (SCA) Month in October, thirteen organizations from across the nation are participating in Screen Across America, a national initiative that provides cardiac screenings to youth ages 5-24. The goal of this collaborative effort is to increase awareness about Sudden Cardiac Arrest in youth and the importance of cardiac screenings and early detection in saving young lives.

3 Oct 2011

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.

3 Oct 2011

Supreme Court hears arguments in Calif. Medicaid case

Justices will hear arguments today regarding California's plan to cut Medicaid payments to doctors, hospitals and other medical providers in an effort to address the state's budget issues. Experts say the case has national implications because its central issue involves states' rights to regulate their Medicaid programs.

3 Oct 2011

Despite increase in cases, awareness of male breast cancer is low

Awareness of male breast cancer is low and most men do not even know they are at risk despite an increase in cases, reveals new research from the University of Leeds.

3 Oct 2011

Hospital execs, other 'local' VIPs tend to get fast care in ER

In a country where the average emergency room wait now tops four hours, it's a rare American patient who doesn't wonder whether a hefty hospital donation or a family connection may be the secret to getting speedier care. Now, it turns out, the answer appears to be yes, at least according to a pair of small but telling surveys that conclude that being a VIP in the ER does come with certain perks.

3 Oct 2011

IOM essential benefits report — long-awaited — expected out later this week

The report will offer the Institute of Medicine's recommendations regarding how the health law's essential benefits package should be determined. In other health law news, federal regulators also must decide whether family planning should be included as a preventive care benefit. Religious groups say the "carve-out" exemption included in the draft regulations is too narrow.

3 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Health issues fuel hostile turn in GOP presidential primary race

The GOP presidential hopefuls all pay homage to Ronald Reagan, but his so-called 11th commandment of politics - Thou shalt not speak ill of any fellow Republican - is being regularly and energetically violated by the two Republican front-runners.

3 Oct 2011

Drug shortages lead to rationing of critical medicines

Though a number of reasons have created the shortfalls, everyone agrees that the proliferation of "gray markets" is one of the biggest factors.

3 Oct 2011

Perinatal exposure to BPA affects mammary hormone response

A recent study accepted for publication in Molecular Endocrinology, a journal of The Endocrine Society, found that perinatal exposure to environmentally relevant doses of bisphenol A (BPA) alters long-term hormone response and breast development in mice that may increase the propensity to develop cancer.

3 Oct 2011

Mayo Clinic expands Medical School to Arizona

Mayo Clinic announced the expansion of Mayo Medical School in Rochester, Minnesota, to Arizona, creating a branch to be called Mayo Medical School -- Arizona Campus.

3 Oct 2011

Potential new drug could treat mixed-lineage leukaemia

A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today.

3 Oct 2011

First Edition: October 3, 2011

Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.

3 Oct 2011

Health Canada approves Trajenta (linagliptin) for type 2 diabetes

Boehringer Ingelheim Canada and Eli Lilly Canada today announced that Health Canada has approved Trajenta (linagliptin), a new oral therapy to improve glycemic control in Canadian adults with type 2 diabetes.

3 Oct 2011

Study sheds new light on relationship of anxiety and high blood pressure to primary aldosteronism

A study that has been published in the Journal of Clinical Endocrinology and Metabolism by an Italian group headed by Nicoletta Sonino (Padova) sheds some new light on the relationship of anxiety and high blood pressure to a hormonal disturbance, primary aldosteronism.

3 Oct 2011

La Jolla Institute scientist identifies previously unknown T cell interaction

Most of the time, the immune system is the body's protector, warding off invading viruses and bacteria before they can lead to infection and disease. But in autoimmune diseases, the immune system does an about face, turning on the body and attacking normal cells.

3 Oct 2011